Table 4 The Comparison of serological CMV markers in Groups
From: Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Groups | ◊CMV IgM (+) patient no/total | CMV IgG avidity >0,8 patient n | * ΨCMV DNA copy/ml | |
|---|---|---|---|---|
Group 1 (n = 7) | Initial | 7/7 | 5 | 2230(166–9240) |
Posttreatment | 0/7 | 3 | 14 (8–1930) | |
Group 2 (n = 5) | Initial | 3/5 | 3 | 2178(158–2917) |
Control | 3/5 | 1 | 1915(656–2900) |